Role of Gut Microbiota in Diabetic HFpEF: Mechanisms and Therapeutic Implications
Diabetes, Metabolic Syndrome and Obesity · Published 2026-08-01 · DOI 10.2147/dmso.s613343
Free full text
Authors (4)
Hongyan Fan, Junli Wu, Yufen Shen, Wenwen Zheng
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Fan, H., Wu, J., Shen, Y., et al. (2026). Role of Gut Microbiota in Diabetic HFpEF: Mechanisms and Therapeutic Implications. Diabetes, Metabolic Syndrome and Obesity. https://doi.org/10.2147/dmso.s613343
Related articles
- Gender-Specific Predictive Utility of Twelve Anthropometric Indices for Metabolic Syndrome in Chinese Lahu Adults with Dyslipidemia · Diabetes, Metabolic Syndrome and Obesity · 2026 · Same journal
- Sleeve Gastrectomy Alters Exosomal miR-497-5p Cargo to Ameliorate Metabolic Dysfunction–Associated Steatotic Liver by Targeting GABARAPL1 · Diabetes, Metabolic Syndrome and Obesity · 2026 · Same journal
- SLC30A8 Promoter Hypomethylation is Associated with Impaired Renal Function in Type 2 Diabetes: A Cross-Sectional Study · Diabetes, Metabolic Syndrome and Obesity · 2026 · Same journal
- The Diabetes Staging System (DSS): A Pilot Study Assessing Feasibility, Provider Engagement and Implementation Challenges of a Novel Staging System for Type 2 Diabetes · Diabetes, Metabolic Syndrome and Obesity · 2026 · Same journal
- The Relationship Between Urinary Neonicotinoid Concentrations and Obesity Among Individuals Aged 35 to 74 in Guangxi, China · Diabetes, Metabolic Syndrome and Obesity · 2026 · Same journal
- Quantifying Metabolic Syndrome Severity: Methodological Evolution, Clinical Validation, and Translational Perspectives · Diabetes, Metabolic Syndrome and Obesity · 2026 · Same journal
- Determinants of Liver Steatosis Progression in Chinese Children: A Prospective Cohort Study · Diabetes, Metabolic Syndrome and Obesity · 2026 · Same journal
- Biofilm–Host Immune Crosstalk at the Diabetic Foot Ulcer Interface: Molecular Mechanisms, Immune Evasion, and Next-Generation Anti-Biofilm Strategies · Diabetes, Metabolic Syndrome and Obesity · 2026 · Same journal
- Hepatogenomics of MAFLD in Asian Population: Genetic Polymorphisms and Pathway-Based Insights · Diabetes, Metabolic Syndrome and Obesity · 2026 · Same journal
- Inhibition of TWEAK/Fn14 Ameliorates Sarcopenic Obesity by Restoring Mitochondrial Biogenesis via the AMPK/SIRT1/PGC-1α Axis · Diabetes, Metabolic Syndrome and Obesity · 2026 · Same journal